Older AML patients show promising response in drug study

Older patients with acute myloid leukaemia (AML) who were once told that nothing could be done for them are finding new hope - and life - through a clinical trial at The Ohio State University Comprehensive Cancer Centre - James Cancer Hospital and Solove Research Institute...

Read the whole article on

More from